NEW YORK — Information technology firm Atos said today that it will build and manage a computational and data storage infrastructure for a pilot genomic platform under development for a French precision medicine initiative.
The platform — called GCS Auragen — is part of the Plan France Médecine Génomique 2025 (PFMG), a €670 million ($752.8 million) initiative the French government launched to sequence individual genomes as part of a national personalized medicine project. Under the PFMG, two platforms are being built: one serving northern France, the other serving the south.
Paris-based Atos said its infrastructure will manage all aspects of data generated by GCS Auragen through the initiative, from DNA sequencing to analysis. The work will be done in collaboration with French IT firms Eolas and A2COM.